Shalby Limited (SHALBY) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shalby Limited (SHALBY) has a cash flow conversion efficiency ratio of 0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs138.47 Million ≈ $1.50 Million USD) by net assets (Rs10.03 Billion ≈ $108.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SHALBY net asset quality score to measure how much of total assets are equity-financed.
Shalby Limited - Cash Flow Conversion Efficiency Trend (2012–2026)
This chart illustrates how Shalby Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SHALBY cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Shalby Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shalby Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hi-Tech Pipes Limited
NSE:HITECH
|
-0.011x |
|
Servet Gayrimenkul Yatirim Ortakligi AS
IS:SRVGY
|
0.005x |
|
5paisa Capital Ltd
NSE:5PAISA
|
-0.098x |
|
ONWARD MEDICAL BV EO -12
F:63E
|
N/A |
|
Avantium Holding BV
AS:AVTX
|
-0.112x |
|
KlaraBo Sverige AB Series B
ST:KLARA-B
|
0.000x |
|
Akwel SA
PA:AKW
|
0.048x |
|
Taigen Biopharmaceuticals Holdings Ltd
TWO:4157
|
0.043x |
Annual Cash Flow Conversion Efficiency for Shalby Limited (2012–2026)
The table below shows the annual cash flow conversion efficiency of Shalby Limited from 2012 to 2026. For the full company profile with market capitalisation and key ratios, see Shalby Limited market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs10.06 Billion ≈ $108.76 Million |
Rs-333.59 Million ≈ $-3.61 Million |
-0.033x | -5.48% |
| 2025-03-31 | Rs9.95 Billion ≈ $107.64 Million |
Rs-313.01 Million ≈ $-3.39 Million |
-0.031x | -261.73% |
| 2024-03-31 | Rs10.08 Billion ≈ $108.99 Million |
Rs195.96 Million ≈ $2.12 Million |
0.019x | -73.39% |
| 2023-03-31 | Rs9.28 Billion ≈ $100.32 Million |
Rs677.73 Million ≈ $7.33 Million |
0.073x | +238.40% |
| 2022-03-31 | Rs8.76 Billion ≈ $94.76 Million |
Rs189.17 Million ≈ $2.05 Million |
0.022x | -78.64% |
| 2021-03-31 | Rs8.35 Billion ≈ $90.27 Million |
Rs843.49 Million ≈ $9.12 Million |
0.101x | +45.86% |
| 2020-03-31 | Rs7.99 Billion ≈ $86.43 Million |
Rs553.74 Million ≈ $5.99 Million |
0.069x | +57.31% |
| 2019-03-31 | Rs7.80 Billion ≈ $84.34 Million |
Rs343.47 Million ≈ $3.71 Million |
0.044x | +140.70% |
| 2018-03-31 | Rs7.62 Billion ≈ $82.35 Million |
Rs139.34 Million ≈ $1.51 Million |
0.018x | -92.71% |
| 2017-03-31 | Rs2.75 Billion ≈ $29.79 Million |
Rs691.74 Million ≈ $7.48 Million |
0.251x | +1118.55% |
| 2016-03-31 | Rs2.22 Billion ≈ $23.97 Million |
Rs45.68 Million ≈ $494.01K |
0.021x | -97.14% |
| 2015-03-31 | Rs1.71 Billion ≈ $18.47 Million |
Rs1.23 Billion ≈ $13.33 Million |
0.722x | +1936.93% |
| 2014-03-31 | Rs1.43 Billion ≈ $15.51 Million |
Rs50.81 Million ≈ $549.49K |
0.035x | -96.07% |
| 2013-03-31 | Rs1.06 Billion ≈ $11.43 Million |
Rs953.70 Million ≈ $10.31 Million |
0.902x | +2100.17% |
| 2012-03-31 | Rs892.99 Million ≈ $9.66 Million |
Rs-40.27 Million ≈ $-435.50K |
-0.045x | -- |
About Shalby Limited
Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology servic… Read more